+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Particle Therapy Market by Type, Products, Services, System, Cancer Type, Application - Forecast to 2023

  • ID: 4699461
  • Report
  • Region: Global
  • 139 Pages
  • Markets and Markets
1 of 6
The Particle Therapy Market is Projected to Grow at a CAGR of 9.3% During the Forecast Period

FEATURED COMPANIES

  • Advanced Oncotherapy PLC.
  • Danfysik A/S
  • Hitachi, Ltd.
  • Provision Healthcare, LLC
  • MORE

Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023

“The particle therapy market is projected to grow at a CAGR of 9.3% during the forecast period”

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. The growth of this market is largely driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.

“The cyclotrons segment is expected to account for the largest market share during the forecast period”

Based on type, the particle therapy products market is segmented into cyclotrons, synchrotrons, and synchrocyclotrons. The cyclotrons segment is expected to account for the largest share of this market in 2018. The development of technologically advanced systems, advantages offered by cyclotrons over other accelerators, and the growing adoption of cyclotrons among users are the major factors driving the growth of this market segment. Furthermore, the leading player in the particle therapy market with the strongest global footprint—IBA—majorly manufactures cyclotrons. This has greatly boosted the adoption of these products.

“The research applications segment is estimated to grow at the highest rate during the forecast period”

On the basis of application, the particle therapy market has been segmented into treatment and research applications. The research applications segment is estimated to grow at the highest rate during the forecast period due to factors such as the growing awareness about the research applications of particle therapy systems, development of cost-effective and technologically advanced diagnostic and therapeutic particle therapy systems, and the increasing industry-academia collaborations in the field of research.

“North America to account for the second-largest share of the global market in 2018”

The particle therapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is expected to account for the second-largest share of the global particle therapy market in 2018. Technological advancements in the field of particle therapy, the rising incidence of cancer, easy accessibility to treatments, and the high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure by the US and Canadian governments) are some of the key factors supporting the growth of the North American market. Furthermore, favorable government initiatives that are creating awareness and promoting the adoption of proton therapy among key end users are some of the other major factors driving the growth of the particle therapy market in North America.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1–25%, Tier 2–30%, and Tier 3–45%
  • By Designation: C-level–26%, Director-level–30%, and Others–44%
  • By Region: North America–35%, Europe–26%, APAC–23%, and RoW–16%

The major players in the market include Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Oncotherapy Plc. (UK), and Danfysik A/S (Denmark).

Research Coverage
This report studies the particle therapy market based on type, product & service, system, cancer type, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the particle therapy market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Advanced Oncotherapy PLC.
  • Danfysik A/S
  • Hitachi, Ltd.
  • Provision Healthcare, LLC
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Volume-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Particle Therapy: Market Overview
4.2 Regional Analysis: Particle Therapy Market, By Product & Service
4.3 Particle Therapy Market Size, By Type
4.4 Particle Therapy Market Size, By Cancer Type
4.5 Regional Analysis: Particle Therapy Market, By Application
4.6 Particle Therapy Market, By Region

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advantages Offered By Particle Therapy Over Photon Therapy
5.2.1.2 Growing Global Prevalence of Cancer
5.2.1.3 Growing Adoption of Particle Therapy in Clinical Trials
5.2.1.4 Increasing Number of Particle Therapy Centers Worldwide
5.2.2 Restraints
5.2.2.1 Infrastructural Challenges in Healthcare Facilities
5.2.2.2 Affordability and Accessibility of Treatments
5.2.2.3 Unfavorable Reimbursement Policies and Limited Insurance Coverage for Particle Therapy
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.4 Industry Trends
5.2.4.1 Growing Adoption of Pencil-Beam Scanning

6 Particle Therapy Market, By Type
6.1 Introduction
6.2 Proton Therapy
6.2.1 Proton Therapy is Increasingly Being Adopted as A Primary Treatment Mode for Various Cancer Types
6.3 Heavy Ion Therapy
6.3.1 The Use of Heavy Ion Therapy is Still in the Experimental Phase Across Many Regions

7 Particle Therapy Market, By Product & Service
7.1 Introduction
7.2 Products
7.2.1 Cyclotrons
7.2.1.1 Leading Players in the Particle Therapy Market Mainly Manufacture Cyclotrons
7.2.2 Synchrotrons
7.2.2.1 Increasing Investments Into the Development of Synchrotron Facilities are Contributing to Market Growth
7.2.3 Synchrocyclotrons
7.2.3.1 The High Space Requirements of Synchrocyclotrons are Limiting Their Widespread Adoption
7.3 Services

8 Particle Therapy Market, By System
8.1 Introduction
8.2 Multi-Room Systems
8.2.1 Lower Shielding Requirements and Faster Beam-Switching Capabilities of Multi-Room Systems are Increasing Interest Among End Users
8.3 Single-Room Systems
8.3.1 Compact Structure and Reduced Capital Costs are Leading to High Growth of Single-Room Systems

9 Particle Therapy Market, By Cancer Type
9.1 Introduction
9.1.1 Pediatric Cancer
9.1.1.1 Better Control of Radiation With Particle Therapy Makes It the Most Suitable Treatment Mode for Pediatric Cancer
9.1.2 Prostate Cancer
9.1.2.1 Particle Therapy Offers A Minimally Invasive Alternative With Increased Accuracy for Prostate Cancer Treatment
9.1.3 Lung Cancer
9.1.3.1 Rising Number of Clinical Trials to Optimize the Use of Particle Therapy for Lung Cancer is Driving the Growth of the Market
9.1.4 Breast Cancer
9.1.4.1 Limited Radiation Exposure With Reduced Side-Effects is Increasing the Adoption of Particle Therapy for Breast Cancer
9.1.5 Head and Neck Cancer
9.1.5.1 The Use of Pencil-Beam Scanning for Proton Therapy Supports Market Growth for This Segment
9.1.6 Other Cancers

10 Particle Therapy Market, By Application
10.1 Introduction
10.2 Treatment Applications
10.2.1 Introduction of Small Footprint Single-Room Particle Therapy Centres is Promoting the Adoption of Particle Therapy for Cancer Treatment
10.3 Research Applications
10.3.1 Increasing Availability of Funding for Particle Therapy-Related Research Projects is Providing Growth Opportunities in Research Applications

11 Particle Therapy Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 Growing Number of Particle Therapy Centers in the US to Drive Market Growth
11.2.2 Canada
11.2.2.1 Canadian Government Undertaking Initiatives to Include Particle Therapy as A Treatment Method
11.3 Europe
11.3.1 France
11.3.1.1 Increasing Healthcare Expenditure in France is Supporting the Adoption of Particle Therapy Products
11.3.2 Germany
11.3.2.1 Increasing Research in the Field of Proton & Heavy Ion Therapy to Drive the Growth of the Particle Therapy Market in Germany
11.3.3 UK
11.3.3.1 Cyclotrons Segment Dominated the Particle Therapy Market  in the UK
11.3.4 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.1.1 Japan is the Largest User of Heavy Ion Therapy for the Treatment of Various Types of Cancers
11.4.2 China
11.4.2.1 Growing Interest of Major Market Players to Increase Their Presence in China Will Drive the Growth of the Particle Therapy Market in the Country
11.4.3 India
11.4.3.1 Leading Product Manufacturers are Entering the Indian Particle Therapy Market Owing to the High Growth Opportunities in the Country
11.4.4 Rest of Asia Pacific
11.5 Rest of the World
11.5.1 Inadequate Healthcare Infrastructure is Restraining the Widespread Adoption of Particle Therapy in the Region

12 Competitive Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Product Launches and Approvals
12.3.2 Acquisitions
12.3.3 Expansions
12.3.4 Agreements and Collaborations

13 Company Profiles: Particle Therapy Market
13.1 Varian Medical Systems, Inc.
13.2 Ion Beam Applications Sa (IBA)
13.3 Mevion Medical Systems, Inc.
13.4 Provision Healthcare, LLC
13.5 Sumitomo Heavy Industries, Ltd.
13.6 Hitachi, Ltd.
13.7 Optivus Proton Therapy, Inc.
13.8 Protom International, Inc.
13.9 Advanced Oncotherapy PLC.
13.10 Danfysik A/S

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details

List of Tables
Table 1 Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 2 Proton Therapy Market, By Region, 2016–2023 (USD Million)
Table 3 Heavy Ion Therapy Market, By Region, 2016–2023 (USD Million)
Table 4 Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 5 Particle Therapy Product & Service Market, By Region, 2016–2023 (USD Million)
Table 6 Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 7 Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 8 Particle Therapy Products Market, By Region, 2016–2023 (USD Million)
Table 9 Cyclotrons Market, By Region, 2016–2023 (USD Million)
Table 10 Cyclotrons Market, By Region, 2016–2023 (Units)
Table 11 Synchrotrons Market, By Region, 2016–2023 (USD Million)
Table 12 Synchrotrons Market, By Region, 2016–2023 (Units)
Table 13 Synchrocyclotrons Market, By Region, 2016–2023 (USD Million)
Table 14 Synchrocyclotrons Market, By Region, 2016–2023 (Units)
Table 15 Particle Therapy Services Market, By Region, 2016–2023 (USD Million)
Table 16 Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 17 Particle Therapy Market for Multi-Room Systems, By Region, 2016–2023 (USD Million)
Table 18 Particle Therapy Market for Single-Room Systems, By Region, 2016–2023 (USD Million)
Table 19 Particle Therapy Market, By Cancer Type, 2016–2023 (USD Million)
Table 20 Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 21 Particle Therapy Market for Treatment Applications, By Region, 2016–2023 (USD Million)
Table 22 Particle Therapy Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 23 Particle Therapy Market, By Region, 2016–2023 (USD Million)
Table 24 North America: Particle Therapy Market, By Country, 2016–2018 (USD Million)
Table 25 North America: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 26 North America: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 27 North America: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 28 North America: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 29 North America: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 30 North America: Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 31 US: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 32 US: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 33 US: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 34 Canada: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 35 Canada: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 36 Canada: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 37 Europe: Particle Therapy Market, By Country, 2016–2018 (USD Million)
Table 38 Europe: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 39 Europe: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 40 Europe: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 41 Europe: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 42 Europe: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 43 Europe: Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 44 France: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 45 France: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 46 France: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 47 Germany: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 48 Germany: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 49 Germany: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 50 UK: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 51 UK: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 52 UK: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 53 RoE: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 54 RoE: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 55 RoE: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 56 Asia Pacific: Particle Therapy Market, By Country, 2016–2018 (USD Million)
Table 57 Asia Pacific: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 58 Asia Pacific: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 59 Asia Pacific: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 60 Asia Pacific: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 61 Asia Pacific: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 62 Asia Pacific: Particle Therapy Market, By Application, 2016–2023 (USD Million)
Table 63 Japan: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 64 Japan: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 65 Japan: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 66 China: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 67 China: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 68 China: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 69 India: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 70 India: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 71 India: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 72 RoApac: Particle Therapy Market, By Product & Service, 2016–2018 (USD Million)
Table 73 RoApac: Particle Therapy Products Market, By Type, 2016–2018 (USD Million)
Table 74 RoApac: Particle Therapy Products Market, By Type, 2016–2018 (Units)
Table 75 RoW: Particle Therapy Market, By Product & Service, 2016–2023 (USD Million)
Table 76 RoW: Particle Therapy Market, By Type, 2016–2023 (USD Million)
Table 77 RoW: Particle Therapy Products Market, By Type, 2016–2023 (USD Million)
Table 78 RoW: Particle Therapy Products Market, By Type, 2016–2023 (Units)
Table 79 RoW: Particle Therapy Market, By System, 2016–2023 (USD Million)
Table 80 RoW: Particle Therapy Market, By Application, 2016–2023 (USD Million)

List of Figures
Figure 1 Particle Therapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation: Particle Therapy Market
Figure 4 Top-Down Approach Market Size Estimation: Particle Therapy Product Market
Figure 5 Top-Down Approach Market Size Estimation: Particle Therapy Services Market
Figure 6 Data Triangulation Methodology
Figure 7 Particle Therapy Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Particle Therapy Products Market Share, By Type, 2018 vs 2023
Figure 9 Regional Analysis: Particle Therapy Market, By System, 2018 (USD Million)
Figure 10 Particle Therapy Market Share, By Cancer Type, 2018 vs 2023
Figure 11 Particle Therapy Market, By Application, 2018 vs 2023 (USD Million)
Figure 12 Particle Therapy Market: Geographical Snapshot
Figure 13 Increasing Cancer Prevalence is Driving Growth of the Particle Therapy Market
Figure 14 Services Segment to Witness High Growth in the APAC Market During the Forecast Period
Figure 15 Proton Therapy Will Dominate the Market During the Forecast Period (2018–2023)
Figure 16 Pediatric Cancer Segment Will Grow at the Fastest Rate in the Market During the Forecast Period
Figure 17 Treatment Application Segment is Estimated to Hold the Largest Share of the Market Globally in 2018
Figure 18 Asia Pacific to Witness Fastest Growth During the Forecast Period (2018–2023)
Figure 19 Growing Incidence of Cancer, By Region, 2012–2020 (Thousands)
Figure 20 Proton Therapy Segment to Dominate the Particle Therapy Market During the Forecast Period
Figure 21 Cyclotrons Segment to Dominate the Particle Therapy  Products Market
Figure 22 Multi-Room Systems Segment to Dominate the Particle Therapy Market During the Forecast Period
Figure 23 Pediatric Cancer Segment to Witness Highest Growth in the Particle Therapy Market During the Forecast Period
Figure 24 Treatment Applications to Dominate the Particle Therapy Market During the Forecast Period
Figure 25 Asia Pacific to Register the Highest Growth in the Particle Therapy Market During the Forecast Period
Figure 26 Number of Particle Therapy Facilities Present (As of October 2018) & Under Construction Across the Globe
Figure 27 North America: Particle Therapy Market Snapshot
Figure 28 Europe: Particle Therapy Market Snapshot
Figure 29 Asia Pacific: Particle Therapy Market Snapshot
Figure 30 RoW: Particle Therapy Market Snapshot
Figure 31 Key Developments By Leading Market Players in the Particle Therapy Market, 2015–2018
Figure 32 Particle Therapy Market Share, By Key Player, 2017
Figure 33 Varian Medical Systems, Inc.: Company Snapshot
Figure 34 Ion Beam Applications Sa: Company Snapshot
Figure 35 Sumitomo Heavy Industries: Company Snapshot
Figure 36 Hitachi, Ltd.: Company Snapshot

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Advanced Oncotherapy PLC.
  • Danfysik A/S
  • Hitachi, Ltd.
  • Ion Beam Applications Sa (IBA)
  • Mevion Medical Systems, Inc.
  • Optivus Proton Therapy, Inc.
  • Protom International, Inc.
  • Provision Healthcare, LLC
  • Sumitomo Heavy Industries, Ltd.
  • Varian Medical Systems, Inc.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4699461
Adroll
adroll